• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Advisorshares Psychedelics ETF (NY: PSIL )

    0.9375 +0.0075 (+0.81%)
    Official Closing Price Updated: 8:00 PM EDT, Jul 9, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 168,519
    Open 0.9469
    Bid (Size) 0.9300 (2)
    Ask (Size) 0.9480 (1)
    Prev. Close 0.9300
    Today's Range 0.9340 - 0.9469
    52wk Range 0.9300 - 2.249
    Shares Outstanding 58,000
    Dividend Yield 0.32%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Top And Flop ETFs Of The First Half
    In this article, we have highlighted three ETFs each from the best and worst-performing zones in the first half of 2024. 
    Via Talk Markets
    Topics ETFs
    Best And Worst ETF Zones Of Q2
    After the worst monthly decline in many months in April, global stock markets have staged a nice comeback on renewed Fed rate cut bets, ongoing artificial intelligence (AI) developments and strong... 
    Via Talk Markets
    Topics Artificial Intelligence ETFs Economy
    Exposures Artificial Intelligence Interest Rates

    Performance

    YTD
    -35.79%
    -35.79%
    1 Month
    -13.19%
    -13.19%
    3 Month
    -35.81%
    -35.81%
    6 Month
    -39.52%
    -39.52%
    1 Year
    -54.71%
    -54.71%

    More News

    Read More
    Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment
    Via Benzinga
    Exposures Product Safety
    Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
    Via Benzinga
    Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
    Via Benzinga
    Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
    Via Benzinga
    Mental Health Mavericks: 3 Stocks Changing the Game
    Via InvestorPlace
    Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More
    Via Benzinga
    Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
    Via Benzinga
    Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More
    Via Benzinga
    Psyched: Ibogaine For TBI, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, Atai's $50M And More
    Via Benzinga
    Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More
    Via Benzinga
    Psychedelic Drug Stocks Index Up In December; Down YTD
    Via Talk Markets
    Psyched: Biden's Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And More
    Via Benzinga
    Psychedelic Drug Stocks Index Declined 1.6% This Week
    Via Talk Markets
    Topics ETFs
    Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More
    Via Benzinga
    5 Largest Psychedelic Compound-Based Drug Stocks Up 3% Last Week
    Via Talk Markets
    Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More
    Via Benzinga
    Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    GH Research Drags Down Psychedelic Drug Stocks Index By 7%
    Via Talk Markets
    Psyched: Veterans & Psychedelics, $100M IPO, Cybin's $64M Offering, Worldwide Events & More
    Via Benzinga
    Topics Initial Public Offering
    Exposures Securities Market
    Psyched: DEA's Denial Overruled, Fed Psychedelics Change, Psilocybin For Depression, States Reform & More
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Psyched: Cybin's Center Stage In Novel Psychedelics, Musk & Ramaswamy, Britney's Memoirs And More
    Via Benzinga
    Topics Intellectual Property
    Exposures Intellectual Property
    Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.